Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received an average rating of "Hold" from the thirty-five analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, twenty-one have issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $54.59.
Several analysts have recently commented on TDOC shares. Bank of America raised their target price on shares of Teladoc Health from $36.00 to $42.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 6th. Piper Sandler reduced their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research note on Thursday, July 28th. KeyCorp assumed coverage on shares of Teladoc Health in a report on Thursday, September 15th. They set a "sector weight" rating for the company. StockNews.com upgraded shares of Teladoc Health to a "sell" rating in a report on Tuesday, August 9th. Finally, Stifel Nicolaus lowered their price target on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th.
Get
Teladoc Health alerts:
Insider Buying and Selling
In related news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total transaction of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,318 shares of company stock worth $255,321. Insiders own 1.55% of the company's stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. ARK Investment Management LLC raised its stake in Teladoc Health by 2.9% during the first quarter. ARK Investment Management LLC now owns 19,466,931 shares of the health services provider's stock worth $1,404,150,000 after acquiring an additional 544,733 shares in the last quarter. Vanguard Group Inc. increased its position in Teladoc Health by 0.7% in the first quarter. Vanguard Group Inc. now owns 13,238,243 shares of the health services provider's stock worth $954,875,000 after purchasing an additional 98,181 shares during the period. Kinnevik AB publ bought a new position in Teladoc Health during the fourth quarter worth about $458,235,000. Renaissance Technologies LLC boosted its holdings in Teladoc Health by 879.2% during the second quarter. Renaissance Technologies LLC now owns 4,475,319 shares of the health services provider's stock worth $148,625,000 after buying an additional 4,018,300 shares during the last quarter. Finally, State of Michigan Retirement System bought a new position in Teladoc Health during the second quarter worth about $123,089,000. 92.46% of the stock is owned by institutional investors.
Teladoc Health Price Performance
Shares of NYSE TDOC opened at $28.00 on Friday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health has a twelve month low of $24.67 and a twelve month high of $156.82. The stock has a 50 day moving average of $32.86 and a two-hundred day moving average of $40.58. The stock has a market cap of $4.51 billion, a P/E ratio of -0.46 and a beta of 0.93.
Teladoc Health (NYSE:TDOC – Get Rating) last issued its quarterly earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.71) by $0.27. The firm had revenue of $592.38 million during the quarter, compared to the consensus estimate of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. On average, research analysts forecast that Teladoc Health will post -1.54 earnings per share for the current year.
Teladoc Health Company Profile
(Get Rating)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Featured Articles
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Don't Give Up on These Q3 Losers
- The Anatomy of a Great Pension Plan
- 3 Safe Earnings Plays for a Risk-Off Market
- Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
- Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
